Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 4862, June 15, 2008. doi: 10.1158/0008-5472.CAN-08-0074
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pervin, S.
Right arrow Articles by Chaudhuri, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pervin, S.
Right arrow Articles by Chaudhuri, G.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Increased Susceptibility of Breast Cancer Cells to Stress Mediated Inhibition of Protein Synthesis

Shehla Pervin1, An H. Tran1, Shaghayegh Zekavati1, Jon M. Fukuto2, Rajan Singh1,3 and Gautam Chaudhuri1,2,4

1 Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles; 2 Department of Molecular and Medical Pharmacology; 3 Division of Endocrinology and RCMI Molecular Medicine Core Laboratory at Charles Drew University of Medicine and Science; and 4 Jonsson Comprehensive Cancer Center, Los Angeles, California

Requests for reprints: Shehla Pervin, Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles, 13-952 Factor Building, 650 Charles Young Drive, South, Los Angeles, CA 90095. Phone: 310-794-5793; Fax: 310-206-5991; E-mail: spervin{at}mednet.ucla.edu.

Key Words: NO • translation • PKR • cyclin D1 • eIF2-{alpha}

Protein synthesis is a tightly controlled process, and its deregulation plays an important role in tumorigenesis. Protein synthesis remains poorly understood with very few well-identified validated targets for therapeutic purposes. In this study, we use nitric oxide (NO), which suppresses protein synthesis by inactivating eukaryotic initiation factor 2-{alpha} (eIF2-{alpha}), to examine the mechanism by which low and high oxidative stress inhibits protein synthesis. In breast cancer cells, low NO stress induced heme-regulated inhibitor (HRI) activation, which facilitated gradual decline in short half-life proteins. High NO stress induced HRI and protein kinase R (PKR) activation, leading to a sharp decline in protein synthesis as accessed by a decline in short and long half-life proteins and dramatic morphologic changes. In contrast, human mammary epithelial (HME) and Ras transfected untransformed HME (MCF-10A1 neo N) cells were less susceptible to NO-induced inhibition of protein synthesis and cytostasis. Our results suggest that NO-induced cytostasis in breast cancer cells was due to PKR activation and increased phosphorylation of eIF2-{alpha}, whereas the reduced susceptibility of normal mammary epithelial cells to NO could be due to the inaccessibility of PKR, which is bound to inhibitor p58. [Cancer Res 2008;68(12):4862–74]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.